Rocket Pharmaceuticals, Inc. Accrued Employee Benefits, Current
Rocket Pharmaceuticals, Inc. (RCKT) had Accrued Employee Benefits, Current of $0 as of 2019-12-31, per its 10-K filed 2020-03-06.
Discontinued › Notes › Accrued Liabilities, Current › Employee-related Liabilities, Current
us-gaap:AccruedEmployeeBenefitsCurrent · last filed 2020-03-06
- 2019-12-31: Accrued Employee Benefits, Current $0.00.
- 2019-03-31: Accrued Employee Benefits, Current $0.00.
- 2018-12-31: Accrued Employee Benefits, Current $7.00K.
- 2018-09-30: Accrued Employee Benefits, Current $160.00K.
| Period end | Accrued Employee Benefits, Current | Accrued Employee Benefits, Current as first filed |
|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-06 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $7.00K 10-K · filed 2020-03-06 | |
| 2018-09-30 | $160.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $388.00K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $891.00K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $138.00K 10-K · filed 2019-03-08 | $270.00K 10-K · filed 2018-03-07 |
| 2017-09-30 | $930.00K 10-Q · filed 2017-11-08 | |
| 2016-12-31 | $544.00K 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |